Tagged: DST Group

2016 TT Sector Wrap Up

2016 has been a big year for technology transfer offices in Australia. As we all know, commercialising research is a tough gig and some deals are many years in the making.  The beginning of a new tradition, KCA has compiled a highlights list from offices around the country to celebrate the achievements of the membership across the year just gone.  You may have heard of some of these achievements throughout the year, but its always nice to look at these things in summary, and consider at what has been accomplished as a group.  Below are some top 3 highlights from offices within the KCA community who were able to participate in the exercise this year.

ANSTO

  • Successful technology transfer and scale up of the ANSTO Minerals Sileach™ process with Lithium Australia.  More info here.
  • ANSTO in partnership with Minomic have successfully developed the MILGa drug for SPECT diagnosis of certain cancers. Minomic is mid-way through a Phase 1 clinical trial.  Story here.
  • ANSTO Health obtained a license from the TGA for production of Lutetium 177, an emerging therapeutic isotope for a range of cancers.  Story here.

CSIRO

  • Launch and expansion of the ON Accelerator to all Public Sector Research Organisations and Universities funded through NISA.  More info here.
  • The announcement of the $200 million CSIRO Innovation Fund to be operational in 2017 and also available to all Public Sector Research Organisations and Universities. More info here.
  • 5 spin outs/equity deals in calendar 2016 and $60m in IP (royalty and licensing) revenue in 2015/16 FY (Chryos, Cardihab, MetaBloQ, Smart Battery)

Curtin

  • West Tech Fest, which incorporates the OzAPP Awards judging, a Startup Village, pitching opportunities, an angel investor dinner, student tech fest, technology startup events and an industry conference.
  • Curtin spinout ePAT technologies listed on the ASX completing a $4.7 million capital raise.
  • Curtin completed a deal with Australian mining services company, Gekko Systems to commercialise a breakthrough gold processing monitoring technology.  Story here.

DST Group

  • HPRNet – DST Group in partnership with the Australian Army has established new model for establishing research networks(Rnet) of Australian Universities to undertake research in areas of interest to Defence .  The first such RNet is a joint initiative of DST Group and the Australian Army which has brought together 7 Australian universities to work in the area of the advancement of human performance . Next year will see this model being used in other technology areas.
  • External Engagement Manager program – 12 month professional development and immersive program whereby  DST researchers are appointed as their respective Research Division’s External engagement manager. As a result of the program researchers have not only increased their business acumen and commercial skills but 60% of the researchers have gained promotions back inside their research areas.
  • CERA business model – Devised the business model whereby the Defence Science Institute (DSI) released a pilot Competitive Evaluation Research Agreement (CERA) program, which sought research proposals from Australian universities relating to projects of Defence strategic importance. In a highly competitive field DSI made award grants of up to $50k each to seed collaborations. The strongest applicants were able to collaborate and engage with Australian industry and International partners. Given the success of the pilot program DST Group has requested the program be continued in the coming financial year.

Griffith

  • Griffith University and agricultural product company Agnova Technologies collaborated to produce Fruition, the nation’s first non-toxic commercial response to fruit flies.  Story here.
  • Student enterprise (student entrepreneurial education is a key growth area for Griffith.  Story here.
  • Olymvax invests in Griffith vaccine for Strep A.  Story here.

LaTrobe

  • La Trobe establishes the new Office of the Pro Vice-Chancellor (Industry Engagement). Story here.
  • Unlocking regional Victoria’s big ideas – LaunchVic funded Regional Accelerator Program.  Story here.
  • Optus and La Trobe tech-collaboration to deliver an integrated, digitally connected campus; a state-of-the-art Sports Precinct of the Future; and creation of a market leading Cyber Security tertiary degree.  Story here.

Macquarie

  • Macquarie University has had one or more team(s) in every CSIRO ON program that were eligible to Universities; Modular Photonics in ACCELERATE 2, LuciGem, FAIMS and Diamond Lasers in PRIME and LuciGem in ACCELERATE 3.
  • 2016 has seen over a double increase in Innovation Disclosures since 2015 (57 as of 08 Dec 2016)
  • We arranged a educational and fun team bonding session with the Research Office, Office of Commercialisation and Innovation and Corporate Engagement by holding a 1 day negotiation training workshop.

Monash

  • BioCurate is an $80M collaboration between Monash and the University of Melbourne established to transform our ability to translate our world class biomedical research into new therapeutic products.  Story here.
  • Monash University spinout Amaero Engineering entered into a major production deal with French based multinational company Safran to produce 3D printed parts for Safran. Story here and here.
  • Monash and Hudson Institute of Medical Research entered into a major commercialisation and co-development deal to develop next generation immunology therapeutics. Story here.

UniQuest

  • A €15 million (A$22 million) Series A investment (one of the largest biotech Series A investments for intellectual property originating from an Australian university) in Inflazome Ltd, a company founded on research from UQ and Trinity College Dublin, developing treatments for inflammatory diseases.  Story here.
  • UniQuest’s Queensland Emory Drug Discovery Initiative (QEDDI) became a fully-equipped and operational drug discovery and development capability, with facilities and staff based at UQ’s Institute for Molecular Bioscience.
  • UQ spinout company Protagonist Therapeutics Inc. listed on the NASDAQ stock market, raising US$90 million (A$118 million) in its initial public offering, (story here), while ResApp is developing a smartphone medical application for the diagnosis and management of respiratory disease, and has raised more than A$16 million since listing on the Australian Stock Exchange in 2015 (story here).

UniSA Ventures

  • UniSA’s Venture Catalyst program voted Australia’s Best Entrepreneurial Support Initiative in the KCA Awards.  Story here.
  • UniSA signed a MoU with one of China’s leading drug development and pharmaceuticals manufacturers, to support the development of new drugs, and treatments in stem cell biology and drug reformulation technology.  Story here.
  • UniSA  launched a new strategic plan for research and innovation to fast-track the development of high potential innovations through UniSA Ventures.  Story here.

UNSW Innovations

  • China Cable deal worth $20m that was KCA deal of the year.  Story here.
  • Quantum Computing deal which saw $25m of Commonwealth funding through NISA, and $10m each from CBA and Telstra to develop a prototype circuit.  Story here.
  • Torch Innovation Precinct announcement that the first Torch Science Park outside China would be set-up at UNSW.  More info here.

UWA

  • A new drug for the treatment of Duchenne Muscular Dystrophy (DMD) originally developed at The University of Western Australia has been approved by the US Food and Drug Administration.  Story here.
  • The first ever Western Australian Innovation Strategy was launched by the Minister for Innovation, the Hon Bill Marmion, on 2 November 2016.  Story here.
  • An increase in support activity for entrepreneurship and innovation in Perth, i.e. CERI is an independent, not-for-profit organisation that has been set up to work closely with local researchers to assist them in developing entrepreneurial skills and to then take them through the Innovation Process, with the goal of assisting them to establish a startup company.

Victoria

  • Researchers at Victoria University have joined forces with Phillip Island Nature Parks to develop a ‘wand’ that harvests oil absorbing  magnetic particles in order to save the lives of penguins and other birds contaminated after an oil spill event.  Story here.
  • A patent and trademark technology licence to a company in Japan to commercialise innovative insole technology develop at ISEAL (Institute of Sport, Exercise & Active Living) research institute as well as leveraging our reputation and famous associated brand. The insoles have major biomechanical advantages over the existing products in the market. Deals are currently being negotiated with major insole and shoe manufacturers and distributors in Asia and beyond to bring this inventive product to market.
  • A patent technology licence to an Australian company to exploit membrane distillation technology. The technology has energy and practical advantages that the company has secured investment and is building a pilot plant to scale up the technology. The company already has end market customers interested in using the technology in a broad range of industrial applications.

Melbourne’s a KCA Commercialisation Awards Triple Winner – Largest Biotech deal for 2014, Red Tape Reduction Management Systems and People’s Choice

Knowledge Commercialisation Australasia (KCA) Research Commercialisation Awards has all three winners from Melbourne, which were announced last night at its annual conference dinner also in Melbourne.

Group_photo_winners_2015

Success lay with the University of Melbourne which won Best Commercial Deal for the largest biotech start-up in 2014; the Melbourne office of the Defence Science and Technology Group which won Best Creative Engagement Strategy for its reducing red tape framework; and Swinburne University for the People’s Choice Award.

“These awards are all about celebrating the achievements of those who are bringing research knowledge to life, and recognising their unique contributions in enabling business and the wider community to benefit from the application of research outputs,” said KCA Executive Officer, Melissa Geue.

Details of the winners are as follows:

The Best Commercial Deal is for any form of commercialisation of knowledge which is innovative in its approach, provides value-add to the research institution and has significant long term social and economic impact:

University of Melbourne – Largest bio tech start-up for 2014

This was for Australia’s largest biotechnology deal in 2014 which was Shire Plc’s purchase of Fibrotech Therapeutics P/L – a University of Melbourne start-up – for US$75 million upfront and up to US$472m in following payments. Fibrotech develops novel drugs to treat scarring prevalent in chronic conditions like diabetic kidney disease and chronic kidney disease. This is based on research by Professor Darren Kelly (Department of Medicine St. Vincent’s Hospital).

Shire are progressing Fibrotech’s lead technology through to clinical stages for Focal segmental glomerulosclerosis, which is known to affect children and teenagers with kidney disease. The original Fibrotech team continues to develop the unlicensed IP for eye indications in a new start-up OccuRx P/L.

Best Creative Engagement Strategy showcases some of the creative strategies research organisations are using to engage with industry partner/s to share and create new knowledge:

Defence Science and Technology Group –Defence Science Partnerships (DSP) reducing red tape with a standardised framework

The DSP has reduced transaction times from months to weeks with over 300 agreements signed totalling over $16m in 2014-15. The DSP is a partnering framework between the Defence Science Technology Group of the Department of Defence and more than 65% of Australian universities. The framework includes standard agreement templates for collaborative research, sharing of infrastructure, scholarships and staff exchanges, simplified Intellectual Property regimes and a common framework for costing research. The DSP was developed with the university sector in a novel collaborative consultative approach.

The People’s Choice Awards is open to the wider public to vote on which commercial deal or creative engagement strategy project deserves to win. The winner this year, who also nabbed last award is:

Swinburne University of Technology – Optical data storage breakthrough leads the way to next generation DVD technology

Using nanotechnology, Swinburne Laureate Fellowship project researchers Professor Min Gu, Dr Xiangping Li and Dr Yaoyu Cao achieved a breakthrough in data storage technology and increased the capacity of a DVD from a measly 4.7GB to 1,000TB. This discovery established the cornerstone of a patent pending technique providing solutions to the big data era. In 2014, start-up company, Optical Archive Inc. licensed this technology. In May 2015, Sony Corporation of America purchased the start-up, with knowledge of them not having any public customers or a final product in the market. This achievement was due to the people, the current state of development and the intellectual property within the company.

Wrays Patent Attorneys were the major sponsor of the 2015 Awards:

Wrays’ CEO Frank Hurley said: “In supporting the KCA Research Commercialisation Awards, we hope to promote an understanding around intellectual property value in the commercialisation process. The two award categories acknowledge both creative business strategy and commercial acumen, which reflects Wrays’ ethos and ties in closely with the services we provide to our clients. Sponsoring KCA is part of an overall vision to nurture relationships with future entrepreneurs by enabling them to protect and generate wealth from their innovations.”

Media Contact

Sharon Kelly (gemaker)

E: s.kelly@gemaker.com.au

M: +61 414 780 077